Asset Management One Co. Ltd. Buys 12,085 Shares of Corteva, Inc. $CTVA

Asset Management One Co. Ltd. grew its stake in shares of Corteva, Inc. (NYSE:CTVA) by 3.7% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 343,122 shares of the company’s stock after acquiring an additional 12,085 shares during the quarter. Asset Management One Co. Ltd. owned about 0.05% of Corteva worth $23,205,000 as of its most recent SEC filing.

Several other large investors have also recently modified their holdings of CTVA. Gladwyn Financial Advisors Inc. purchased a new stake in Corteva during the 2nd quarter valued at about $25,000. True Wealth Design LLC lifted its stake in shares of Corteva by 209.5% in the third quarter. True Wealth Design LLC now owns 390 shares of the company’s stock worth $26,000 after buying an additional 264 shares in the last quarter. Total Investment Management Inc. purchased a new stake in shares of Corteva during the second quarter valued at approximately $27,000. Curat Global LLC increased its position in shares of Corteva by 93.7% during the second quarter. Curat Global LLC now owns 370 shares of the company’s stock valued at $28,000 after acquiring an additional 179 shares in the last quarter. Finally, Maryland Capital Advisors Inc. purchased a new position in Corteva in the 2nd quarter worth approximately $29,000. Hedge funds and other institutional investors own 81.54% of the company’s stock.

Corteva Trading Up 0.2%

Corteva stock opened at $67.90 on Tuesday. Corteva, Inc. has a 52-week low of $53.40 and a 52-week high of $77.41. The company has a market cap of $45.88 billion, a P/E ratio of 29.02, a P/E/G ratio of 1.39 and a beta of 0.74. The company has a quick ratio of 1.07, a current ratio of 1.58 and a debt-to-equity ratio of 0.07. The business has a 50-day simple moving average of $65.61 and a two-hundred day simple moving average of $68.88.

Corteva (NYSE:CTVA) last posted its quarterly earnings data on Tuesday, November 4th. The company reported ($0.23) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.49) by $0.26. The company had revenue of $2.62 billion for the quarter, compared to the consensus estimate of $2.47 billion. Corteva had a net margin of 9.19% and a return on equity of 9.37%. The firm’s revenue was up 6.5% compared to the same quarter last year. During the same quarter last year, the firm posted ($0.49) earnings per share. Analysts predict that Corteva, Inc. will post 2.96 EPS for the current year.

Corteva Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, December 15th. Stockholders of record on Monday, December 1st were paid a $0.18 dividend. This represents a $0.72 annualized dividend and a dividend yield of 1.1%. The ex-dividend date was Monday, December 1st. Corteva’s dividend payout ratio is 30.77%.

Analysts Set New Price Targets

Several brokerages have commented on CTVA. The Goldman Sachs Group increased their target price on Corteva from $77.00 to $78.00 and gave the company a “buy” rating in a research note on Tuesday, December 16th. BMO Capital Markets set a $86.00 price objective on Corteva in a report on Monday, September 15th. Rothschild & Co Redburn lowered their target price on shares of Corteva from $71.00 to $65.00 and set a “neutral” rating on the stock in a research note on Tuesday, November 11th. Citigroup raised shares of Corteva from a “neutral” rating to a “positive” rating in a report on Thursday, December 18th. Finally, Royal Bank Of Canada decreased their price objective on shares of Corteva from $86.00 to $80.00 and set an “outperform” rating for the company in a report on Friday, October 17th. Sixteen equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $78.21.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.